Azize Pınar Metbulut

Azize Pınar Metbulut

Auto-generated profile, based on publicly available information

Azize Pınar Metbulut

Pediatric Immunology and Allergy Department, Ankara Bilkent City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
AMAzize Pınar Metbulut
Azize Pınar Metbulut
IHİdIl Akay Haci
İdIl Akay Haci
DCDemet Can
Demet Can
HBHayrunnisa Bekis Bozkurt
Hayrunnisa Bekis Bozkurt
OCOzlem Cavkaytar
Ozlem Cavkaytar
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu

24 September 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
OTOzge Yilmaz Topal
Ozge Yilmaz Topal
AMAyse Metin
Ayse Metin
ICİlKnur Kulhas Celik
İlKnur Kulhas Celik
AMAzize Pinar Metbulut
Azize Pinar Metbulut
SASelma Alim Aydin
Selma Alim Aydin
APAslinur Ozkaya Parlakay
Aslinur Ozkaya Parlakay
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, and the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pandemic in mid-March of 2020.

8 February 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
AMAzize Pınar Metbulut
Azize Pınar Metbulut
APAslınur Özkaya Parlakay
Aslınur Özkaya Parlakay
GBGülsüm İclal Bayhan
Gülsüm İclal Bayhan
SYSaliha Kanık Yüksek
Saliha Kanık Yüksek
BGBelgin Gülhan
Belgin Gülhan
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu
Severe acute respiratory syndrome causing coronavirus (SARS‐CoV‐2) is a new corona virus responsible for the pandemic named Coronavirus Disease 2019(COVID‐19). Although the pathogenesis of the disease has not been completely understood yet, it may cause clinical pictures with various degrees of multisystem involvement(1,2).

1 January 2024 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ŞYŞule Büyük Yaytokgi̇l
Şule Büyük Yaytokgi̇l
KDKezban İpEk Demi̇r
Kezban İpEk Demi̇r
ÖTÖzge Yılmaz Topal
Özge Yılmaz Topal
AMAzize Pınar Metbulut
Azize Pınar Metbulut
IÇİlKnur Külhaş Çeli̇k
İlKnur Külhaş Çeli̇k
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu
Data on the prevalence of allergic diseases in children with proven drug allergies are limited. We aim to evaluate thefrequency of allergic comorbidity in children with proven common drug allergies.Materials and methods: Children with drug hypersensitivity confirmed by diagnostic allergy tests at our center between January 2010and December 2020 were screened retrospectively. Patients with the most common drug allergies (due to antibiotics, nonsteroidalantiinflammatory drugs [NSAIDs], and antiepileptic drugs) were selected for analysis. Age, sex, the culprit drug, initial reactioncharacteristics, diagnostic test results, and the study physician who diagnosed concomitant allergic diseases were noted.Results: A total of 168 patients (boys, 51.2%) with a median age of 12 years (IQR = 8–16.3) were included in the study. The culprit drugwas an antibiotic in 63% (n = 106), NSAID in 25% (n = 42) and anticonvulsant in 11.9 % (n = 20) of the patients. Drug hypersensitivityreactions were immediate in 74.4 % (n = 125) and delayed in 25.6 % (n = 43) of the patients. Seventy-five patients (44.6 %) had at leastone allergic disease, most commonly rhinitis (27.3 %, n = 46) or asthma (25 %, n = 42). Fifty-five patients underwent skin prick testswith aeroallergens, producing a positive result in 60% (n = 31). The prevalence of allergic disease was not differing according to theculprit drug. The frequency of developing at least one concomitant allergic disease was 47.2% (n = 50/106) for antibiotic hypersensitivity,52.4% (n = 22/42) for NSAID hypersensitivity, and 15% (n = 3/20) for anticonvulsant hypersensitivity (p < 0.00).Immediate drug hypersensitivity reactions were more frequent in children who had allergic diseases (80 % vs. 64.5 %; p = 0.027).Conclusion: Nearly half (44.6%) of the children with proven drug hypersensitivity had concomitant allergic diseases and immediatereactions were more common in this group. Children evaluated for drug hypersensitivity should be assessed for other allergic diseases.

28 April 2025 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
AMAzize Pınar Metbulut
Azize Pınar Metbulut
IHİdIl Akay Haci
İdIl Akay Haci
DCDemet Can
Demet Can
HBHayrunnisa Bekis Bozkurt
Hayrunnisa Bekis Bozkurt
OCOzlem Cavkaytar
Ozlem Cavkaytar
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu

28 January 2022 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
AMAyşe Metin
Ayşe Metin
AMAzize Pınar Metbulut
Azize Pınar Metbulut
ÖGÖmer Güneş
Ömer Güneş
GBGülsüm İcLal Bayhan
Gülsüm İcLal Bayhan
GCGüzin Cinel
Güzin Cinel
AKAbdurrahman Kara
Abdurrahman Kara
Kronik granülomatöz hastalık (CGD), tekrarlayan, yaşamı tehdit eden bakteri ve mantar enfeksiyonları ile karakterize olan, granülom oluşumuna yol açan genetik olarak heterojen bir primer immün yetmezlik olan fagosit fonksiyon yetersizliğidir. Erken teşhis, klinisyenin hastalığın erken enfeksiyon ipuçları konusunda bilinçlenmesi ile mümkündür. CGD hastalarında Enfeksiyöz komplikasyonların agresif tedavisi çok önemlidir ve hematopoietik kök hücre nakline kadar antimikrobiyal (antibiyotik ve antifungal) ve immünomodülatör (interferon-gama) profilaksileri de çok önemlidir. Mortalitenin azalmasına rağmen, CGD ile ilişkili komplikasyonlara bağlı morbiditeler önemini korumaktadır. Bunlardan biri, CGD hastasında, hastaların dörtte birinden fazlasında görülen ve aynı zamanda çok dirençli ve sıklıkla sık morbiditeli birden fazla ameliyat gerektiren karaciğer apsesidir. Bu nedenle dünyada halen en uygun ve faydalı tedaviler araştırılmaktadır. Granülosit transfüzyonları ile birlikte perkütan karaciğere yönelik girişimsel radyolojik tedavi ile tedavi edilen S.aureus ve Aspergillus spp’ye bağlı çoklu karaciğer apsesi olan 3 yaşında bir CGD hastasını sunuyoruz. Chronic granulomatous disease (CGD) is a genetically heterogeneous primary immune deficiency of phagocyte function characterized by recurrent, life-threatening bacterial and fungal infections that lead to granuloma formation. Early diagnosis is possible by the awareness of the clinician about early infectious clues of the disease. Aggressive treatment of infectious complications is very important in CGD patients and subsequently antimicrobial (antibiotic and antifungal) and immunomodulatory (interferon-gamma) prophylaxis until hematopoietic stem cell transplantation. Despite improved mortality, morbidities due to complications associated with CGD remain significant. One of these is a hepatic abscess in CGD patients which is seen in more than one-quarter of patients and also very refractory and frequently requires multiple surgeries with frequent morbidities. Therefore, the most optimal and beneficial treatments are still being investigated in the world. We present a 3 y old CGD patient with multiple liver abscesses due to S.aureus and Aspergillus spp who treated by several percutaneous liver-directed interventional radiological treatment along with granulocyte transfusions